The 2020 ISPE Asia Pacific Pharmaceutical Manufacturing Virtual Conference and Executive Forum provides you with access to regulatory intelligence on emerging supply chain, quality, and compliance challenges in light of COVID-19. Participate in actionable, interactive discussions featuring case studies and dedicated Q&A time with experts representing global health authorities, including FDA and MHRA.
Benefit from unparalleled real-time engagement with regulatory leaders as they share companies' best practices to assess critical manufacturing processes and lessons learned to improve and sustain a reliable supply of quality medicine. Plus, stay knowledgeable throughout the year with on demand access to ALL session recordings and presentations for 12 months.
The Executive Forum, led by global regulators and industry leaders, is an interactive discussion forum for pharmaceutical executives. The focus of this year’s Forum will be on post-COVID-19 assessment of the impact on the pharmaceutical supply chain and lessons learned for the pharmaceutical manufacturing industry.
Collaboratively explore opportunities facing pharmaceutical leaders and regulators to develop strategies for enhanced supply chain visibility and control.
*The Forum is included with Conference Registration
Attendees will be able to:
Executive Level Leaders in Pharmaceutical and Biopharmaceutical Supply Chain
Manufacturing & Operations professionals Quality Assurance professionals Quality Control professionalsRegulatory Body personnel Regulatory Affairs experts Pharma Senior Level Managers